Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 2Neuroblastoma 2Rhabdomyosarcoma 1Osteosarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Malignant mesenchymal tumor 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Ifosfamide 19Doxorubicin 19Filgrastim 17Radiotherapy 13Vincristine 11Cyclophosphamide 11Etoposide 9Cisplatin 9Granulocyte Colony-Stimulating Factor 8Gene Expression Profiling 8Trabectedin 7Polymerase Chain Reaction 7Dactinomycin 6sargramostim 5etoposide phosphate 5Paclitaxel 5Mesna 5Chemotherapy, Adjuvant 4Brachytherapy 4pegfilgrastim 3Topotecan 3Microarray Analysis 3Irinotecan 3Immunohistochemistry 3Imatinib Mesylate 3Gemcitabine 3Dexrazoxane 3Base Sequence 3olaparib 2brostallicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Sarcoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00066365 2015-03-30

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Children's Oncology Group

Phase 2 Completed
49 enrolled 21 charts
Sarcoma

Neoplasm Metastasis, Sarcoma, Osteosarcoma

NCT00003958 2013-06-17

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
702 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡